Methods of determining whether anti-PACAP (adenylate cyclase-activating peptide) antibodies or anti-PACAP antigen binding fragments inhibit PACAP-associated photophobia or light aversion
Granted 15 Jan 2019 · 2 office actions
Current assignee: H. Lundbeck A/S · originally University of South Florida
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Daniel S. Allison, Andrew F. Russo, Levi P. Sowers, Benjamin H. Dutzar +15 · Examiner: Chang-Yu Wang · AU 1649 · TC 1600
Life of the application
10 dated eventsAbstract
This invention relates to methods of screening for anti-PACAP antibodies, or anti-PACAP receptor antibodies, and antigen binding fragments thereof, for potential use in treating or preventing PACAP-associated photophobia or light aversion, and therapeutic compositions containing and methods of using anti-PACAP antibodies, or anti-PACAP receptor antibodies, and antigen binding fragments thereof.
Claims as granted
11 claimsLog in to read the claims of this application.
Log in to unlockClassifications
11 codes- A61K49/00
- A61K39/00
- A61K45/06
- A61K39/395
- A61K49/16
- C12P21/08
- C07K16/00
- C07K16/26
- G01N33/50
- G01N33/74
- G01N33/53
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this application are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockDocuments
Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.
Log in to unlockChain of title
No assignments have been recorded for this application yet.